To explore the auto-reactive potential of cells infiltrating the gut mucosa in idiopathic chronic inflammatory bowel disease, intestinal lamina propria mononuclear cells (LPMC) were isolated, characterized morphologically and phenotypically, and evaluated for antigen-specific reactivity. The last was assessed by quantitating LPMC cytotoxic capabilities against purified, aqueous-soluble, organ-specific epithelial cell-associated components (ECAC) characterized previously.
Introduction
The process of immune sensitization at the gastrointestinal mucosal level is structurally unique (1, 2) , but, functionally, poorly understood. In view of the large number of dietary and environmental antigens in the lumen of mucosa-bearing organs, for example, it is not clear how the sensitization process is regulated in a way conducive to the development of the most appropriate response for a particular antigenic stimulus. For instance, what signals determine whether a given response is primarily cell mediated or humoral; whether priming remains local or becomes systemic; and whether antigen-specific tolerance or immunity occur. A detailed knowledge of the factors governing the sensitization process is particularly important in the case of disorders characterized by chronic inflammation in mucosa, where immune responses harmful to mucosal epithelial cells have been described (3) (4) (5) . However, most studies of the local inflammatory infiltrate in such diseases have focused on an evaluation of cell number and general immunological function (6) (7) (8) .
We took a different approach to the question of aberrant sensitization at mucosal surfaces through the study of antigenspecific immune responses. We have previously shown that the immune response to gut-associated (salivary) glycoproteins is T lymphocyte-dependent, despite the resemblance of these macromolecules to T-independent antigens by virtue of the repeating nature of their surface epitopes, and that the carbohydrate sidechains, rather than the core apoprotein, are the principal immunogenic moiety (9, 10) . Analogous components have now been isolated from intestinal epithelium, purified to homogeneity, and immune (primarily humoral) reactivity to them defined at the peripheral blood level in patients with chronic inflammatory intestinal diseases (1 1, 12 ). An important objection to such studies, however, is the probable changed nature of the immune response and of the events in the preceding sensitization as well, when one evaluates immunological events at the mucosal rather than at the peripheral blood level: immune mechanisms detected at the periphery may be nonoperative or irrelevant at the mucosal level. In addition, circulating factors with immune regulatory potential such as immunoglobulins, lymphoid cells, and lymphokines may influence mucosal immunological reactivity. Insight into these and other mechanisms for initiation and modulation of antigen-specific reactions in mucosa can best be gained by direct evaluation of immune competent cells populating the intestine itself. Such evaluation has become possible through recently developed techniques for isolating purified mononu-clear cells from the intestinal lamina propria of normal and abnormal mucosa obtained by surgical resection or biopsy (6) (7) (8) 13) .
In this communication, we report that lamina propria mononuclear cells (LPMC),1 isolated from intestine involved by a chronic inflammatory disease, but not from control tissue, exhibit cytotoxicity specific for purified surface components (ECAC) of intestinal epithelium. Characterization of the effector cell suggests that it is a T cell because ECAC-specific reactivity was significantly enhanced by enrichment in cells bearing surface markers of the OKT 3 humidified atmosphere. Unattached cells were then removed, washed, and suspended in culture medium. For purposes of this paper, these nonadherent cells will be defined as adherent cell-depleted LPMC; they contained 2±1.5% macrophages, as determined by nonspecific esterase staining (17) .
Monoclonal antibodypanning technique for T cell and natural killer (NK) cell enrichment of LPMC. As a modification of the technique described by Wysocki and Sato (18), 10 ml of a goat antimouse immunoglobulin solution (Southern Biotechnology Assoc., Birmingham, AL), containing 10 Ag antibody/ml of Tris-buffered saline at pH 9.5, were added to a 100 X 20-mm bacteriological grade plastic dish (Optilux, Becton-Dickinson & Co., Oxnard, CA). The plates were incubated at room temperature for 1 h, washed five times, and stored at 40C for at least 30 min before use.
Adherent cell-depleted LPMC were washed two times in phosphatebuffered saline (PBS) with 5% fetal calf serum (FCS) and resuspended at 20 X 106 cells/ml in the same buffer. OKT 11 or Leu 1 lb monoclonal antibodies (Ortho Immunobiological Research Div., Raritan, NJ; Becton-Dickinson & Co., Research Div., Mt. View, CA) were added at a 1:100 and a 1:250 dilution, respectively, to the cell suspension and incubated at 40C for 30 min, with gentle agitation every 10 min. The monoclonal antibody-coupled LPMC were then pelleted (200 g, 10 min at 4QC) and resuspended at 6 X 106 cells/ml of PBS with 5% FCS.
20-30 X 106 cells were dispersed slowly onto a goat anti-mouse Igcoated plate and incubated at 40C. After 1 h, nonadherent cells were removed by gentle pipetting. Adherent cells were rinsed with PBS containing 5% FCS and removed by several washes performed by gentle pipetting with the same buffer. Both adherent and nonadherent cells were assessed for purity by immunofluorescence (see below): they were found to contain 96±1.7 and 23±8% T lymphocytes, respectively, after OKT 11 treatment. Low numbers of NK cells in unfractionated LPMC (1.3±1.1%) were further reduced in the nonadherent fraction (0.5±0.7%), but were unchanged in the adherent fraction (1.0±0.86%).
SRBC rosetting for T cell depletion of LPMC. To obtain cell preparations depleted of intestinal lamina propria T lymphocytes, E rosette formation followed by Ficoll-Hypaque gradient centrifugation was carried out using SRBC pretreated with aminoethylisothiouronium bromide (Aldrich Chemical Co., Milwaukee, WI) (19) . The cells at the interface were washed, suspended in medium, and assessed for cell type by immunofluorescence (see below); 11.6±5.6% were T lymphocytes.
Monoclonal antibody and surface immunoglobulin methods for cell identification. Unfractionated and fractionated LPMC, at a concentration of 5 X 106 cells/ml, were assayed by resuspending the cells in PBS with 1% BSA, 2% human AB serum, and 0.2% sodium azide. Two 200-Ml aliquots were prepared, one receiving 5 Ml of monoclonal antibody (OKT 3 or Leu 1 lb), the other 5 Al of medium as a reagent control. Cells were mixed thoroughly and placed in an ice-water bath for 30 min and agitated every 10 min. At the end of the incubation time, the cells were washed twice with 2 ml of cold PBS/5% FCS. After the second wash, the supernatant was removed, leaving the cell pellet plus 100 Ml of medium. 100 Ml of diluted (1:20) fluorescein isothiocyanate-conjugated goat anti-mouse IgG was added to each tube, and these were incubated and washed as above. LPMC contained in the final pellet were resuspended in one drop of PBS with 30% glycerol and 0.2% sodium azide. as cpm in a Beckman LS7500 liquid scintillation system. Target antigens. Gut-derived antigens were isolated from murine intestine, as previously described, through mechanical separation of gut epithelial cells, solubilization of epithelium-associated macromolecules in a PBS/10-4 M EDTA solution, and ethanol fractionation (12) . Substances precipitating between 55 and 75% ethanol, upon resolubilization in PBS, dialysis against deionized water and lyophilization, were designated as epithelial cell-associated components (ECAC); materials derived from small bowel (ECAC-SB) and colon (ECAC-C) were separately processed and tested. Precipitation by ethanol as well as other biochemical separation procedures (below) were carried out at 4VC, and all buffers contained 0.5 mM phenylmethyl-sulfonyl fluoride, 8 mM benzamidine (both from Sigma Chemical Co., St. Louis, MO), and 1 U/ml aprotinin (Mobay Chemical Corp., New York, NY) to inhibit proteases. Further, by both hemagglutination inhibition and double diffusion in agar, ECAC-SB and ECAC-C were shown not to contain components immunologically similar to the enterobacterial common antigen of Kunin; the latter, studied in a highly purified form as described (21), was a kind gift of Dr. Hubert Mayer, Max Planck Institute, Freiburg, Federal Republic of Germany.
In order to examine immune reactivity to individual components within ECAC, ECAC-SB was fractionated by preparative polyacrylamide gel electrophoresis. Eight-and three-tenths mg of ECAC-SB, dissolved in 3.0 ml of saline (5% vol/vol in glycerol), was electrophoresed on a nondenaturing 10% polyacrylamide slab gel, pH 8.8, using a Bethesda Laboratory model V161 apparatus (Bethesda Research Laboratories, Gaithersburg, MD). Electrophoresis was carried out at 250C at 25 mA/gel until the bromphenol blue marker reached the end of the gel (-5 h). Using a vertical 1.0-cm gel strip developed with Coomassie Brilliant Blue G250 quick stain as a guide to band location (22) , gel sections (designated P1 through P6, generally containing one component each) were sliced out, minced, and eluted into PBS by mechanical stirring overnight at 4VC. Each supernatant was subsequently ultracentrifuged (65,500g, 45 min), dialyzed against deionized water, and Iyophilized. The purity of each gel-eluted component was assessed by re-electrophoresis on an analytical 10% polyacrylamide gel (Fig. 2) , and immune reactivity as well as antigenic specificity defined both by passive hemagglutination inhibition as well as by immunodiffulsion (described in reference 12).
Elicitation ofspecific antisera. Antibody specific for ECAC-SB and ECAC-C was obtained through subcutaneous injection of 500 ,Ag of each antigen, dissolved in saline, and emulsified in an equal volume of Freund's complete adjuvant (250 Mg Mycobacterium tuberculosis type H37 Ra) (Difco Laboratories, Detroit, MI) into the hind footpads of New Zealand White rabbits. A panel of sera at peak titer was subsequently selected for study by a quantitative hemagglutination assay (9) and antigenic specificity was evaluated by radial immunodiffusion and hemagglutination inhibition (10) .
Lymphocyte-mediated cytotoxicity. For this assay, LPMC and their subpopulations were isolated from inflammatory bowel disease and control patients as described above. Additional control mononuclear cells were isolated from the peripheral blood of a healthy individual by density gradient centrifugation over Ficoll-Hypaque. Viability of the latter cells was >95% in all cases, and platelets were depleted by low-speed centrifugation in medium. For all cytotoxicity experiments, media was RPMI 1640 supplemented with 5% heat-inactivated FCS, 100 U/ml penicillin, and 100 Mg/ml streptomycin. Antibody-dependent cellular cytotoxicity. Recent reports from our laboratory, using peripheral blood mononuclear cells from Crohn's disease patients, suggest that anti-ECAC cytotoxicity can be antibody mediated (12) . Therefore, we tested whether LPMC were also able to effect antibody-dependent cellular cytotoxicity against ECAC. We employed a procedure identical to that described above for lymphocytemediated cytotoxicity, except that heat-inactivated (56°C, 30 min) patients' sera were diluted in medium and pipetted into wells to achieve a final concentration of 1:20, 1:200, and 1:2,000. The formula for percentage specific release was the same as above, although 'experimental now designated supernatant counts in wells containing test serum in addition to LPMC and targets, and "'control specified wells containing control serum, LPMC, and targets. Tested at the same time as controls were known ECAC-specific positive and negative rabbit sera, which had an established titer by hemagglutination to each study antigen of 1:4,000 and <4, respectively.
Inhibition ofthe cytotoxic response by antigen. Two million LPMC in 500 Ml of medium were preincubated with 2 or 8 Ml of inhibitor (ECAC or kidney antigen at 7 mg/ml, or saline) for 1 h at 370C. After three washings (2,000. g, 4 min each), LPMC were added to antigenlabeled target cells in the standard cytotoxicity assay. Percent inhibition was calculated by the formula 1 -(Pexperimental/'control) X 100, as described previously (24) . That these inhibition experiments were carried out in antigen excess was verified through measurement of the capacity of the culture supernate to inhibit a standard anti-ECAC serum, utilizing a technique (passive hemagglutination) developed for glycoproteins and having a sensitivity approaching that of radioimmunoassay in our hands (10 Cell-mediated cytotoxicity ofLPMCfor epithelial antigens. ECAC-specific cytotoxicity of LPMC isolated from seven patients with chronic inflammatory bowel disease was significantly greater (P < 0.02) than that found with control LPMC (Table  I) . Test antigen derived from small intestine (ECAC-SB) and colon (ECAC-C) epithelium were both reactive, compared with control kidney antigen prepared by techniques (solubilization in EDTA/PBS, ethanol fractionation) identical to those used for isolation of ECAC. LPMC from five of seven patients responded to both ECAC preparations. The mean±SD 5"Cr release for the seven control subjects was 0.03±0.08% (ECAC-C) and 0.40±1.05% (ECAC-SB) ( Table I ).
The influence of the effector to target (E/T) ratio was examined in preliminary experiments with LPMC from four patients (Fig. 3) . ECAC-specific cytotoxicity was detectable and near-maximal at an E/T of one whether unfractionated or T lymphocyte-enriched LPMC were used. Reactivity to colon and small bowel-derived ECAC behaved similarly in this regard. Subsequently, unless otherwise stated, cytotoxicity assays were carried out at an E/T of one. The studies which follow were generally performed with inflammatory bowel disease (and not control) LPMC, with the goal of characterizing the ECAC-reactive cell.
Antibody independence of the LPMC cytotoxic response. specific immunoglobulin, the cytotoxic potential of patient LPMC was further assessed in the presence of heterologous hyperimmune ECAC-specific sera (titer by passive hemagglutination > 1:4,000). At a time when the positive control (normal peripheral mononuclear cells) demonstrated an antibody-dependent cytotoxic response to ECAC-C (13.9±4.3%) and to ECAC-SB (25.7±10.4) in the presence of a 1:200 dilution of hyperimmune-specific sera, eight preparations of LPMC, whether from histologically normal (four) or diseaseinvolved intestine, were not augmented by serum (mean increase in cytotoxicity < 0.9±0.6). These data would indicate that antibody-dependent ECAC-specific cytotoxicity is not an important mechanism at the gut level under these conditions. Cytotoxicity with components ofECAC. To assess whether additional antigen purification would reveal the LPMC reactivity to be highly-specific for an individual epithelial component, five macromolecules (from gel slices, P1, P2, and P4-one component each; P3, two components) comprising ECAC-SB and isolated by preparative polyacrylamide gel electrophoresis (Fig. 2) , were each evaluated as targets for cytotoxicity with LPMC from three additional patients with active chronic inflammatory bowel disease (Table II) Effector cell responsible for anti-ECAC reactivity. In initial experiments to characterize the nature of the latnina propria cell causing ECAC-specific cytotoxicity, adherent cells were markedly depleted from LPMC (10±6% reduced to 2±1.5%) by the plastic adherence technique. Compared with unfractionated LPMC, the ECAC-specific cytotoxicity of adherent cell-depleted preparations was retained or enhanced (Table  III) , suggesting that the cytotoxic cell was nonadherent.
Therefore, T lymphocyte-enriched LPMC were prepared from six additional patients, using a panning technique with an established T lymphocyte-specific monoclonal antibody (OKT 11), and assayed for ECAC-specific reactivity. Markedly enhanced cytotoxicity to both ECAC-C and ECAC-SB was demonstrated by the cell preparations enriched in T lymphocytes (96±1.7% T lymphocytes) compared with unfractionated LPMC (P < 0.05) (Table IV) . T lymphocyte-depleted LPMC (23±8% T lymphocytes) retained cytotoxic potential but were not significantly different from unfractionated LPMC (P > 0.30). Use ofan alternative T lymphocyte-specific monoclonal antibody (OKT 3) for cell fractionation of LPMC from two additional patients gave similar findings: a fourfold rise in ECAC-C specific cytotoxicity, comparing unfractionated LPMC (2.5±2.2%) with T lymphocyte-enriched LPMC (11.3±5.3%). Reactivity to kidney control antigen remained low with all cell preparations (Table IV) . This same analysis, when carried out at an E/T ratio of 10, showed similar results (data not shown). These experiments suggested that a T lymphocyte population was responsible for cytotoxicity to ECAC. T lymphocytes remaining in the T lymphocyte-depleted fractions (23±8%) may have accounted for residual reactivity to ECAC in the experiments above. Therefore, a SRBC rosetting technique was used to further reduce the percentage of T lymphocytes in LPMC from four additional patients known to be reactive with ECAC. Compared with unfractionated LPMC, T lymphocyte-depleted preparations (1 1.6±5.6% T lymphocytes) showed a significant reduction in ECAC-specific cytotoxicity (P < 0.05) ( Table V) . This effect was evident at an E/T ratio of 10 (shown in the table) and one (data not shown). Adherent cell-depleted LPMC 6.3±4.9 8.5±4.4 * LPMC, purified by density gradient centrifugation of intestinal mucosal cells released after collagenase treatment, were tested for ECAC-specific cytotoxicity before and after a 120-min incubation at 370C on plastic Petri dishes. Adherence reduced the percentage of macrophages from a mean of 10% (unfractionated LPMC) to 2% (macrophage-depleted LPMC), as assessed by nonspecific esterase staining. t Data are shown as the mean ±SD specific cytotoxic response of LPMC for the indicated antigens at an E/T ratio of 1. § LPMC were from four patients with chronic inflammatory bowel disease. Because NK cells may copurify with T lymphocytes on the basis of similar cell surface markers (receptor for sheep erythrocytes, and glycoprotein detected by OKT 3), we depleted NK cells from LPMC of four additional ECAC-reactive patients in order to assess the contribution of NK to ECAC-specific cytotoxicity. Compared with unfractionated LPMC (4.5±0.4%), nonadherent (NK-depleted) cells retained cytotoxicity toward ECAC-SB (3.9±1.3). Similar results were found with ECAC-C (6.6±2.5% and 4.7±4.1% for unfractionated and NK-depleted LPMC). Immunofluorescence with an NK-specific monoclonal antibody (Leu 1 lb) showed that NK cells constituted a small percentage (1.3±1.1%) of mononuclear cells among LPMC that was further reduced in the depleted (nonadherent) fraction (0.5±0.7%). The number of cells recovered in the adherent fraction (generally < 106) was too small to allow an adequate evaluation of their cytotoxic potential.
Effect of preincubation with ECAC. To further assess the antigenic specificity of the cytotoxic response of both unfrac- 
Discussion
Previous studies have demonstrated that functional LPMC may be prepared from the intestinal mucosa (6) (7) (8) . In extending these studies, we sought to develop a method by which antigen- (Table II) . From their differing Rf values (Fig. 2) , and their individual reactivity with determinant-specific sera (12), we assume that each "P" component is a different macromolecule. One could speculate that a common sensitizing determinant is shared among several epithelial cell-associated components, or that an autoimmune process at the mucosal surface is directed, for reasons not yet understood, to several distinct antigens, a concept more broad than that which we generally envision in experimental models of autoimmune disease (experimental allergic encephalomyelitis, for instance) (37, 38) . Examples of this broad reactivity to self include the autoimmune hemolytic anemias (I, i, P, and Rh-related antigens) and systemic lupus erythematosis (native double-stranded DNA and the phospholipid cardiolipin) in man, as well as experimental autoimmune orchitis (aspermatogenic proteins APl, AP2, GPl, and GP4) in the guinea pig (39-42).
The cytotoxic response that we found should be considered in the context of the murine origin of the study antigens. The presence of species-specific major histocompatibility loci antigens in our preparation cannot be ruled out, but seems unlikely in view of: (a) the tight association of these antigens with cell membranes (43); cells and membranes were pelleted out of the starting material in the current study; (b) the poor aqueoussolubility of histocompatibility antigens when they have been mobilized from cell membranes (44) ; (c) the absence of patient reactivity to murine kidney antigens similarly prepared by dissociation and ethanol fractionation; and (d) the absence of reactivity by LPMC from control patients to these same murine-derived fractions. No immunological cross-reactivity was found between ECAC and the enterobacterial common antigen of Kunin (see Methods), making it less likely that LPMC cytotoxicity is directed toward bacterial antigens. However, Kotz and Roche (45) have recently reported the isolation from human colon of components quite similar to murinederived ECAC; immunological identity was shown by a passive hemagglutination inhibition technique, and individual macromolecules demonstrated similar migratory rates (Rf) by polyacrylamide gel electrophoresis.
Cytotoxic capabilities of LPMC explored in previous work all evaluated nonspecific killing. In general, no differences have been found between LPMC derived from chronic inflammatory bowel disease and control tissue (7, 46), although Shorter et al. (47) recently reported antibody-dependent cellular cytotoxicity and spontaneous cell-mediated cytotoxicity against autologous epithelial cells using, respectively, LPMC from patients with inflammatory bowel disease and other disorders. In contrast, our data suggest, for the first time, that LPMC are capable of antigen-specific cytotoxicity and that this phenomenon is confined to mononuclear cells derived from inflammatory bowel disease-involved intestine, as opposed to cells isolated from histologically normal mucosa. Furthermore, our study shows that cytotoxicity apparently requires specific antigen recognition as a necessary step before destruction of ECACcoated targets. The lack of effect of adherent cell removal from the effector population, the inability of patients and hyperimmune sera to enhance the degree of killing, the increase in cytotoxicity by T cell enrichment and its loss by T cell depletion, all indicate that T lymphocytes are the responsible cells. The possibility that residual NK cells are causative of a portion of the cell lysis is highly unlikely, considering that depletion of this cell subset did not significantly alter LPMC cytotoxicity against ECAC-coated targets. In addition, spontaneous cell-mediated cytotoxicity has not been demonstrated for LPMC (7, 46, 48) , and treatment of LPMC with interferon does not induce cytotoxicity against K562 target cells (Fiocchi, C., R. R. Tubbs, and K. R. Youngman, submitted for publication). We are uncertain why an E/T ratio of one was nearoptimal in our system, except that the further addition of a particular T cell subset may result in overall suppression of antigen-specific responses. This is partly supported by our recent observation that the degree of mitogen-induced proliferation of a mixture of peripheral blood mononuclear cells and LPMC is progressively suppressed as the proportion of LPMC is increased (49). It should be noted that, since we were unable to obtain LPMC from inflamed mucosa of disease other than chronic inflammatory bowel disease, we cannot rule out the possibility that LPMC reactivity to ECAC may be related to disruption of the intestinal epithelial cell barrier. Evidence that a local immunological autosensitization is the primary process will likely depend upon studies of ECAC reactivity among affected and nonaffected members of families with a genetic predisposition to chronic inflammatory bowel disease, and upon investigation in animals intentionally sensitized to intestinal epithelial antigens.
Differences in immune mechanisms for the anti-ECAC response in the intestinal mucosa (reported here as T lymphocyte mediated) compared with that in the peripheral circulation (reported in reference 12 as antibody mediated) deserves comment. In one scheme, B and T lymphocytes, sensitized to antigen within Peyers' patches, could each achieve a different distribution in lymphoid tissue upon their obligatory systemic migration before homing to receptors on high endothelial gut venules (50) . Antigen-specific T lymphocytes, in contrast to other immune cells, may be rather completely recruited back to inflamed mucosa, perhaps because of their involvement in the tissue-destructive response, accounting for their ready detection there and not in the peripheral blood (12) . Alternatively, T lymphocytes specific for ECAC may become activated and numerically expand primarily in mucosa, in response to continued exposure there to the sensitizing antigen. Detection of LPMC reactivity to epithelial cell-associated components, isolated under conditions not requiring cell homogenization with release of intracellular contents, encourages use of these readily obtainable, presumably native macromolecules to explore further the immunochemistry and the immunoregulation of antigen-specific autoimmune phenomena directed toward mucosal epithelium in both man and in the experimental animal.
